Angelini Ventures
Headquarter
Waltham, MA - United States
Milestones
Founded: 2019
Invested: 2021
Founders / CEO
Jay Parrish, CEO
Vertical
Biotech
Board Participation
Paolo di Giorgio, Board Member
Leading mitochondrial disease company, it creates therapies to reverse mitochondrial dysfunction by leveraging a deep mechanistic understanding of mitochondrial biology that can address mitochondrial dysfunction at its roots, enabling patients to effectively treatment of common diseases, including aging-related disorders.
Related news:
Pretzel Therapeutics, eyeing diseases caused by broken mitochondria, launches with $72.5 million